QWM
LUCD icon

Quaker Wealth Management’s Lucid Diagnostics LUCD Stock Holding History

Quaker Wealth Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$345 Buy
+300
New +$382 ﹤0.01% 790

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Quaker Wealth Management's LUCD Position: Q1 2026 in Review

Quaker Wealth Management opened a new position in Lucid Diagnostics (LUCD) in Q1 2026: 300 shares worth $345. The stake represents ﹤0.01% of the portfolio and ranks #790 among its holdings.

103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Quaker Wealth Management held 300 shares of Lucid Diagnostics worth $345 as of Q1 2026.
  • Lucid Diagnostics was a new Quaker Wealth Management position in Q1 2026.
  • Lucid Diagnostics made up ﹤0.01% of Quaker Wealth Management's portfolio in Q1 2026, its #790 holding.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Quaker Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.